CKD Bio Corp. (KRX:063160)
South Korea · Delayed Price · Currency is KRW 13,460
-80 (-0.59%)
Oct 13, 2026, 3:30 PM KST
CKD Bio Market Cap
CKD Bio has a market cap or net worth of 73.84 billion as of October 12, 2026. It is the 29,825th most valuable company in the world and the 1,542nd biggest in South Korea. Its market cap has decreased by 42.48% in one year.
Market Cap
73.84B
Enterprise Value
n/a
Revenue
159.93B
Global Rank
Country Rank
#1,542 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 1, 2002, CKD Bio's market cap has increased from 10.15B to 73.84B, an increase of 627.77%. That is a compound annual growth rate of 8.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 73.84B | -33.86% |
| Dec 30, 2025 | 111.64B | -7.50% |
| Dec 30, 2024 | 120.69B | -7.76% |
| Dec 28, 2023 | 130.84B | 0.21% |
| Dec 29, 2022 | 130.57B | -43.06% |
| Dec 30, 2021 | 229.31B | -47.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kyongbo Pharmaceutical | 131.49B |
| SAMSUNG PHARM. Co., LTD. | 129.51B |
| Dong Sung Bio Pharm.Co.,Ltd. | 120.45B |
| Jeil Pharma Holdings | 115.90B |
| HANDOK | 111.72B |
| Kukje Pharma | 86.95B |
| CMG Pharmaceutical | 83.25B |
| Enzychem Lifesciences | 76.86B |